Abbott Laboratories Gains FDA Approval for Eye Implant
Today, CHI member Abbott Laboratories announced that they have received approval from the U.S. Food and Drug Administration to market an eye implant therapy for cataract patients.
The new intraocular lens, TECNIS Toric, is intended for treatment of cataract patients with pre-existing corneal astigmatism. The device, already available in Europe and Canada, is designed to take the place of lenses removed in cataract surgery, correcting the patients’ loss of focus which stems from the astigmatism.
Approximately 3.5 million cataract surgeries are performed yearly, according to the company.
Read more at Abbott Laboratories .